Supercharge Your Innovation With Domain-Expert AI Agents!

Inhibitors of histone deacetylase

A solvate, alkyl technology, applied in the field of compounds that inhibit histone deacetylase

Inactive Publication Date: 2010-03-24
7503547加拿大公司
View PDF7 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, many HDAC inhibitors inhibit all HDAC isoforms

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Inhibitors of histone deacetylase
  • Inhibitors of histone deacetylase
  • Inhibitors of histone deacetylase

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0291] 2,2-Bis(2,3-Dihydrobenzofuran-5-yl)-N-hydroxyacetamide (3)

[0292] plan 1

[0293]

[0294] Step 1: Methyl 2,2-bis(2,3-dihydrobenzofuran-5-yl)acetate (2)

[0295] To a solution of 1 (992 mg, 3.35 mmol) in methanol (20 mL), concentrated sulfuric acid (2 mL) was added, and the mixture was stirred at 60°C for 15 hours. The solvent was removed under vacuum. The crude material was dissolved in ethyl acetate and washed with water. Separate the organic layer and use Na 2 SO 4 It was dehydrated, dried, filtered, and concentrated to obtain compound 2 as a white solid (2.25 g, 94%). 1 H NMR(DMSO-d 6 )δ(ppm): 7.13(d, J=1.3Hz, 2H), 6.99(dd, J=8.2, 1.8Hz, 2H), 6.68(d, J=8.2Hz, 2H), 5.00(s, 1H) , 4.48 (t, J=8.8 Hz, 4H), 3.63 (s, 3H), 3.12 (t, J=8.8 Hz, 4H).

[0296] Step 2: 2,2-bis(2,3-dihydrobenzofuran-5-yl)-N-hydroxyacetamide (3)

[0297] To a solution of 2 (380 mg, 1.22 mmol) and hydroxylamine (50% in water, 1.25 ml) in 1:1 THF: methanol (10 ml), add alkali (KOH (275 mg, 4.9 mmol) or ...

Embodiment 2

[0299] N-hydroxy-2-phenoxy-2-phenylacetamide (6)

[0300] Scenario 2

[0301]

[0302] Step 1: Ethyl 2-phenoxy-2-phenylacetate (5)

[0303] To a solution of 4 (0.5 g, 2.06 mmol) and phenol (194 mg, 2.06 mmol) in THF (15 mL), add alkali (NaH (60% dispersion, 90 mg, 2.27 mmol) or three Ethylamine) and stirred at room temperature for 2 hours. The reaction mixture was quenched with water, diluted with ethyl acetate, and washed with water. Separate the organic layer and use Na 2 SO 4 Dehydrate, dry, filter, and concentrate. The crude material was purified by silica gel column chromatography with a gradient of ethyl acetate (0-25%) in hexane to obtain 5 as a colorless oil (140 mg, 27%). 1 H NMR(DMSO-d 6 )δ(ppm): 7.55-7.52(m, 2H), 7.44-7.34(m, 3H), 7.30-7.25(m, 2H), 6.96-6.92(m, 3H), 5.96(s, 1H), 4.13 -4.05 (m, 2H), 1.09 (t, J=7.0 Hz, 3H).

[0304] Alternative reaction conditions:

[0305] Compound 4 (1 equivalent), ROH (1 equivalent), K 2 CO 3 (1.5 equivalents), acetone, 50°C, 18 hours. ...

Embodiment 3

[0311] N-hydroxy-2,2-bis(4-nitrophenyl)acetamide (9)

[0312] Scheme 3

[0313]

[0314] Step 1: Methyl 2,2-bis(4-nitrophenyl)acetate (8)

[0315] Compound 7 (6 g, 26.5 mmol) was dissolved in fuming nitric acid (60 mL) and stirred at room temperature for 16 hours. The reaction mixture was poured on ice, and the light yellow sludge formed was separated and then dissolved in ether to provide a solid. Filtration gave the title compound 8 as a white solid (1.15 g, 14%). 1 H NMR(DMSO-d 6 ) δ (ppm): 8.22 (d, J=9.0 Hz, 4H), 7.65 (d, J=8.6 Hz, 4H), 5.76 (s, 1H), 3.72 (s, 3H).

[0316] Step 2: N-hydroxy-2,2-bis(4-nitrophenyl)acetamide (9)

[0317] Following the same procedure as described in step 2 of Example 1, but replacing compound 2 with compound 8, the title compound 9 was obtained in 25% yield (50 mg). 1 H NMR(CD 3 OD-d 4 ) δ (ppm): 8.21 (d, J=8.8 Hz, 4H), 7.61 (d, J=8.6 Hz, 4H), 5.07 (s, 1H). LRMS(ESI): calculated value 317.1, measured value 316.3(M-H)-.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula compounds of the Formula (I) and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mixtures, diastereomers and enantiomers thereof, wherein groups L, M, X and Y are as defined herein.

Description

Technical field [0001] The present invention relates to compounds that inhibit histone deacetylase. [0002] This application claims the rights and interests of US provisional patent application 60 / 922,505 filed on April 9, 2007. Background technique [0003] In eukaryotic cells, nuclear DNA associates with histones to form a tight complex called chromatin. Histones constitute a family of basic proteins, which are generally highly conserved among eukaryotic species. The core histones called H2A, H2B, H3 and H4 associate to form a protein core. DNA wraps around this protein core, where the basic amino acids of histones interact with the negatively charged phosphate groups of DNA. Approximately 146 DNA base pairs wrap around the core of histones to form nucleosomal particles, the repeating structure motif of chromatin. [0004] Csordas, Biochem. J., 286:23-38 (1990) teaches that histones are susceptible to post-translational acetylation of N-terminal lysine residues, which are cata...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07C259/06A61K31/16A61K31/18A61K31/33C07C311/19C07C323/50C07D521/00
CPCC07D207/263C07D213/56C07D413/14C07D239/42C07D295/26C07D401/06C07C311/08C07D413/04C07D285/12C07D211/46C07D491/10C07D211/34C07D317/50C07D213/74C07D491/08C07D513/04C07D209/08C07D213/70C07D267/20C07D233/84C07D295/205C07D409/04C07C259/06C07D239/38C07D307/79C07D205/04C07D277/74C07D211/64C07D471/04C07D417/04C07D207/337C07D295/155C07D215/26C07D219/04C07D209/44C07D235/16C07C275/42C07D333/24C07D239/26C07D235/28C07D211/76C07D295/088C07D401/04C07D417/06C07D311/84C07C323/52C07C311/21C07D249/06C07D277/36C07D213/64C07D239/34C07D211/52C07D295/192C07D231/14A61P3/10A61P9/00A61P25/08A61P25/24A61P29/00A61P31/10A61P31/12A61P35/00A61P37/00C07C235/32C07D307/77C07D407/02C07D407/12
Inventor 皮埃尔·特西尔西尔瓦纳·利特戴维·斯米尔罗伯特·德齐尔阿兰·阿杰米恩伊维斯·A·钱蒂格尼西莉亚·多明格斯
Owner 7503547加拿大公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More